Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007).
Grossi F, Fasola G, Rossetto C, Spizzo R, Meduri S, Sibau A, Vigevani E, Tumolo S, Adami G, Sacco C, Recchia L, Rizzato S, Ceschia T, Belvedere O. Grossi F, et al. Among authors: recchia l. Lung Cancer. 2006 Apr;52(1):89-92. doi: 10.1016/j.lungcan.2005.11.013. Epub 2006 Feb 17. Lung Cancer. 2006. PMID: 16483688 Clinical Trial.
Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001).
Grossi F, Belvedere O, Fasola G, Barbone F, Rizzato S, Sibau A, Recchia L, Vigevani E, Ceschia T, Morelli A, Guglielmi A, Puglisi F, Follador A, Talmassons G, Sobrero AF. Grossi F, et al. Among authors: recchia l. Lung Cancer. 2004 Oct;46(1):99-106. doi: 10.1016/j.lungcan.2004.03.003. Lung Cancer. 2004. PMID: 15364137 Clinical Trial.
Malignant peritoneal mesothelioma: a multicenter study on 81 cases.
Manzini VP, Recchia L, Cafferata M, Porta C, Siena S, Giannetta L, Morelli F, Oniga F, Bearz A, Torri V, Cinquini M. Manzini VP, et al. Among authors: recchia l. Ann Oncol. 2010 Feb;21(2):348-353. doi: 10.1093/annonc/mdp307. Epub 2009 Jul 27. Ann Oncol. 2010. PMID: 19635740 Free article.
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Piedrabuena MA, Correale J, Fiol M, Marrodan M, Rojas JI, Alonso M, Pappolla A, Miguez J, Patrucco L, Cristiano E, Vrech C, Cohen L, Alonso R, Silva B, Luetic G, Deri N, Burgos M, Liwacki S, Piedrabuena R, Tkachuk V, Barboza A, Martinez A, Balbuena ME, Pinheiro AA, Nofal P, Lopez PA, Tavolini D, Leguizamon F, Hryb JP, Tizio S, Recchia L, Reich E, Contentti EC, Marcilla MP, Pagani F, Cabrera LM, Curbelo MC, Mainella C, Liguori NF, Coppola M, Pettinicchi JP, Carra A, Jose G, Nadur D, Bestoso S, Pestchanker C, Vazquez GD, Martinez CM, Ysrraelit MC. Piedrabuena MA, et al. Among authors: recchia l. J Neurol Sci. 2024 Jun 15;461:123052. doi: 10.1016/j.jns.2024.123052. Epub 2024 May 16. J Neurol Sci. 2024. PMID: 38797140
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?
Luetic GG, Menichini ML, Vrech C, Pappolla A, Patrucco L, Cristiano E, Marrodán M, Ysrraelit MC, Fiol M, Correale J, Cohen L, Alonso R, Silva B, Casas M, Garcea O, Deri N, Burgos M, Liwacki S, Tkachuk V, Barboza A, Piedrabuena R, Blaya P, Steinberg J, Martínez A, Carrá A, Tavolini D, López P, Knorre E, Nofal P, Volman G, Carnero Contentti E, Pinheiro AA, Leguizamon F, Silva E, Hryb J, Balbuena ME, Zanga G, Kohler M, Chertcoff A, Lazaro L, Tizio S, Mainela C, Reich E, Recchia L, Blanche J, Marcilla MP, Fracaro ME, Sgrilli G, Divi P, Jacobo M, Cabrera M, Pagani Cassara F, Sinay V, Curbelo C, Míguez J, Coppola M, Liguori NF, Martos I, Pettinicchi JP, Viglione JP, José G, Bestoso S, Manzi R, Vázquez G, Nadur D, Martínez C, Serena MA, Rojas JI. Luetic GG, et al. Among authors: recchia l. Mult Scler Relat Disord. 2022 Feb;58:103401. doi: 10.1016/j.msard.2021.103401. Epub 2021 Nov 17. Mult Scler Relat Disord. 2022. PMID: 35216784
Rebound activity after fingolimod cessation: A case - control study.
Barboza A, Gaitán MI, Alonso R, Ysrraelit MC, Luetic G, Liwacki S, Patrucco L, Halfon MJ, Burgos M, Mainella C, Pierdabuena R, Recchia L, Steinberg J, Tkachuk VA, Zanga G, Carra A, Chertcoff A, Fernandez Liguori N, Lazaro L, Menichini ML, Miguez J, Orzuza G, Palavecino A, Pappolla A, Pigretti S, Pita C, Ruiz E, Silva B, Zentil G. Barboza A, et al. Among authors: recchia l. Mult Scler Relat Disord. 2022 Jan;57:103329. doi: 10.1016/j.msard.2021.103329. Epub 2021 Oct 13. Mult Scler Relat Disord. 2022. PMID: 35158443
Imaging of Pancreatic Neuroendocrine Neoplasms.
Chiti G, Grazzini G, Cozzi D, Danti G, Matteuzzi B, Granata V, Pradella S, Recchia L, Brunese L, Miele V. Chiti G, et al. Among authors: recchia l. Int J Environ Res Public Health. 2021 Aug 24;18(17):8895. doi: 10.3390/ijerph18178895. Int J Environ Res Public Health. 2021. PMID: 34501485 Free PMC article. Review.
30 results